
==== Front
Arch Virol
Arch. Virol
Archives of Virology
0304-8608 1432-8798 Springer-Verlag Vienna 

1200844
BF01317429
10.1007/BF01317429
Article
Immunity following intranasal administration of an inactivated, freeze-dried A/England/42/72 vaccine
Potter C. W.  Jennings R.  McLaren C.  Clarke A.  grid.11835.3e0000000419369262Academic Division of Pathology (Virology), University of Sheffield Medical School, Sheffield, Yorkshire England 
1975 
48 4 307 316
3 4 1975 6 5 1975 © Springer-Verlag 1975This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.Summary
A group of 23 student volunteers were each inoculated intranasally with 400 IU of inactivated, freeze-dried A/England/42/72 vaccine. Only one volunteer showed a four-fold rise in serum HI antibody following immunization, and the mean increase in serum HI antibody (gmt) for all volunteers did not increase two-fold. Thirteen of the volunteers developed detectable levels of nasal wash neutralizing antibody after immunization; local antibody was most commonly found in volunteers who also produced a detectable but less than four-fold rise in serum antibody titre, and who produced nasal washings with relatively high concentrations of protein and secretory IgA. Four weeks after immunization, the vaccinees and a matched group of control subjects were inoculated with attenuated A/England/42/72 (MRC-7) virus. Evidence of infection was found in 14 of 23 (61 per cent) of control subjects and in seven of 23 (30 per cent) of immunized volunteers. This result showed a significant protection (P=0.04) against challenge virus infection for volunteers given intranasal vaccine.

Keywords
Infectious DiseaseVirus InfectionControl SubjectAntibody TitreDetectable Levelissue-copyright-statement© Springer-Verlag 1975
==== Refs
References
Couch, R. B., Douglas, R. G., Rossen, R., Kasel, J. A.: Role of secretory antibody in influenza. In: The Secretory Immune System, pp. 93–113. U.S. Department of Public Health. 1969.
Davenport F. M.  Hennessy A. V.  Brandon F. M.  Webster R. G.  Barrett C. D. Jr.  Lease G. O.   Comparisons of serological and febrile responses in humans to vaccination with influenza A viruses and their haemagglutinins Labor. clin. Med. 1964 63 5 13 
Downie J. C.  Stuart-Harris C. H.   The production of neutralizing activity in serum and nasal secretion following immunization with influenza B virus J. Hyg. 1970 68 233 244 5270204 
Fahey J. L.  McLaughlin C.   Preparation of antisera specific for 6.6 S γ-globulins, β2 A-globulins, γ-macroglobulins and for type I and II common γ-globulin determinants J. Immunol. 1963 91 484 497 14082035 
Fazekas de St. Groth S.  Withell J.  Lafferty K. J.   An improved assay for neutralization antibodies against influenza viruses J. Hyg. 1958 56 415 426 13587991 
Gwaltney J. M. Jr.  Edmondson W. P. Jr.  Rothenberg R.  White P. W.   A comparison of subcutaneous, nasal and combined vaccination. I. Antigenicity Amer. J. Epidemiol. 1971 93 472 479 5562719 
Haigh W.  Howell R. W.   The efficacy of the A2/Aichi/68 strain in inhaled influenza immunization against A/England/42/72 variant J. Soc. Occupational Med. 1973 23 125 127 
Haigh W.  Howell R. W.  Meichen F. W.   A comparative trial of influenza immunization by inhalation and hypojet methods The Practitioner 1973 211 365 370 4586238 
Hobson, D., Beare, A. S., Ward-Gardner, A.: Haemagglutinin-inhibiting serum antibody titres as an index of response of volunteers to intranasal infection with live, attenuated strain of influenza virus. Proceedings of the Symposium of Live Influenza Vaccines, Zagreb, 1971, pp. 73–84 (Yugoslav Academy of Science and Arts, 1972).
Kasel J. A.  Horne E. B.  Fulk R. V.  Togo Y.  Huber M.  Hornick R. B.   Antibody responses in nasal secretions and serum of elderly persons following local and parenteral immunization of inactivated influenza virus vaccines J. Immunol. 1969 102 555 562 5773312 
Liem K. S.  Marcus E. A.  Jacob J.  van Strick R.   The protective effect of intranasal immunization with inactivated influenza virus vaccine Postgrad. med. J. 1973 49 175 179 4607227 
Lowry O. H.  Rosebrough N. J.  Farr A. L.  Randall R. J.   Protein measurement with the Folin phenol reagent J. biol. Chem. 1951 193 265 275 14907713 
Mancini G.  Carbonara A. O.  Heremans J. F.   Immunochemical quantitation of antigens by single radial immunodiffusion Immunochem. 1965 2 235 254 
Meiklejohn G.  Kempe C. H.  Tahalman W. G.  Lennette E. H.   Evaluation of monovalent influenza vaccines. II. Observations during an influenza A-prime epidemic Amer. J. Hyg. 1952 55 12 21 14885162 
Perkins J. C.  Tucker D. N.  Knoft H. L. S.  Wenzel R. P.  Kapikian A. Z.  Chanock R. M.   Evidence for the protective effect of an inactivated rhinovirus vaccine given by the nasal route Amer. J. Epidemiol. 1969 90 319 326 4309899 
Potter C. W.  Stuart-Harris C. H.  McLaren C.   Antibody in respiratory secretions following immunization with influenza virus vaccines. International Symposium on Influenza vaccines in man and horses, London, 1972 Symposium Series Immunobiological Standards 1973 20 198 207 
Potter, C. W., Jennings, R., McLaren, C., Clarke, A.: Immune response in volunteers to intranasal inoculation with freeze-dried influenza A/Hong Kong/68 vaccine. J. biol. Stand. (in press) (1975).
Quilligan J. J.  Francis T. Jr.  Minuse E.   Reactions to an influenza virus vaccine in infants and children Amer. J. Dis. Child. 1949 78 295 301 18138926 
Reed L. J.  Muench H.   A simple method for estimating 50 per cent endpoints Amer. J. Hyg. 1938 27 493 497 
Rosenbaum M. J.  Mammen R. E.  Edwards E. A.  Frazier W. E.  Peckinpaugh R. O.  Tauraso N. M.   Effect of dose and route of immunization on the antibody response of humans to A/PR/8/34 (H0N1) influenza vaccine. International Symposium on influenza in man and horses, London, 1972 Symposium Series Immunobiological Standards 1973 20 191 197 
Sever J. L.   Application of a microtechnique to viral serological investigations J. Immunol. 1962 88 320 329 13910995 
Shore S. L.  Potter C. W.  Stuart-Harris C. H.   Antibody response to inactivated influenza vaccine given by different routes in patients with chronic bronchopulmonary disease Thorax 1974 28 721 728 
Smith C. B.  Purcell R. H.  Bellanti J. A.  Chanock R. M.   Protective effect of antibody to para-influenza type I virus New Engl. J. Med. 1966 275 1145 1152 4288591 
Waldman R. H.  Kasel J. A.  Fulk R. V.  Mann J. J.  Togo Y.  Hornick R. B.  Heiner G. T.  Dawkins A. T.   Influenza antibody in human respiratory secretion following subcutaneous or nasopharyngeal immunization with inactivated vaccine Nature 1968 218 594 595 5655193 
Waldman R. H.  Mann J. J.  Small P. A. Jr.   Immunization against influenza: prevention of illness in man by aerosolized inactivated vaccine J. Amer. Med. Ass. 1969 207 520 524 
Waldman R. H.  Wood S. H.  Torres E. J.  Small P. A. Jr.   Influenza antibody response following aerosol administration of inactivated virus Amer. J. Epidemiol. 1970 91 575 584 
Waldman R. H.  Coggins W. J.   Influenza Immunization: Field trial on a University campus J. infect. Dis. 1972 126 242 248 4559743 
Wenzel R. P.  Hendley J. O.  Sande M. A.  Gwaltney J. M. Jr.   Revised (1972 to 1973) bivalent influenza vaccine J. Amer. Med. Ass. 1973 226 435 438

